Literature DB >> 35325236

Stabilization of the SARS-CoV-2 receptor binding domain by protein core redesign and deep mutational scanning.

Alison C Leonard1, Jonathan J Weinstein2, Paul J Steiner1, Annette H Erbse3, Sarel J Fleishman2, Timothy A Whitehead1.   

Abstract

Stabilizing antigenic proteins as vaccine immunogens or diagnostic reagents is a stringent case of protein engineering and design as the exterior surface must maintain recognition by receptor(s) and antigen-specific antibodies at multiple distinct epitopes. This is a challenge, as stability enhancing mutations must be focused on the protein core, whereas successful computational stabilization algorithms typically select mutations at solvent-facing positions. In this study, we report the stabilization of SARS-CoV-2 Wuhan Hu-1 Spike receptor binding domain using a combination of deep mutational scanning and computational design, including the FuncLib algorithm. Our most successful design encodes I358F, Y365W, T430I, and I513L receptor binding domain mutations, maintains recognition by the receptor ACE2 and a panel of different anti-receptor binding domain monoclonal antibodies, is between 1 and 2°C more thermally stable than the original receptor binding domain using a thermal shift assay, and is less proteolytically sensitive to chymotrypsin and thermolysin than the original receptor binding domain. Our approach could be applied to the computational stabilization of a wide range of proteins without requiring detailed knowledge of active sites or binding epitopes. We envision that this strategy may be particularly powerful for cases when there are multiple or unknown binding sites.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  FuncLib; Rosetta; SARS-CoV-2; deep mutational scanning; immunogen design

Mesh:

Substances:

Year:  2022        PMID: 35325236      PMCID: PMC9077414          DOI: 10.1093/protein/gzac002

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.952


  50 in total

1.  The stability effects of protein mutations appear to be universally distributed.

Authors:  Nobuhiko Tokuriki; Francois Stricher; Joost Schymkowitz; Luis Serrano; Dan S Tawfik
Journal:  J Mol Biol       Date:  2007-03-31       Impact factor: 5.469

2.  An Automated Data-Driven Pipeline for Improving Heterologous Enzyme Expression.

Authors:  Emily E Wrenbeck; Matthew A Bedewitz; Justin R Klesmith; Syeda Noshin; Cornelius S Barry; Timothy A Whitehead
Journal:  ACS Synth Biol       Date:  2019-02-08       Impact factor: 5.110

3.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.

Authors:  Jun Lan; Jiwan Ge; Jinfang Yu; Sisi Shan; Huan Zhou; Shilong Fan; Qi Zhang; Xuanling Shi; Qisheng Wang; Linqi Zhang; Xinquan Wang
Journal:  Nature       Date:  2020-03-30       Impact factor: 49.962

4.  Characterizing Protein-Protein Interactions Using Deep Sequencing Coupled to Yeast Surface Display.

Authors:  Angelica V Medina-Cucurella; Timothy A Whitehead
Journal:  Methods Mol Biol       Date:  2018

5.  Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.

Authors:  Ching-Lin Hsieh; Jory A Goldsmith; Jeffrey M Schaub; Andrea M DiVenere; Hung-Che Kuo; Kamyab Javanmardi; Kevin C Le; Daniel Wrapp; Alison G Lee; Yutong Liu; Chia-Wei Chou; Patrick O Byrne; Christy K Hjorth; Nicole V Johnson; John Ludes-Meyers; Annalee W Nguyen; Juyeon Park; Nianshuang Wang; Dzifa Amengor; Jason J Lavinder; Gregory C Ippolito; Jennifer A Maynard; Ilya J Finkelstein; Jason S McLellan
Journal:  Science       Date:  2020-07-23       Impact factor: 47.728

6.  DNA vaccine protection against SARS-CoV-2 in rhesus macaques.

Authors:  Jingyou Yu; Lisa H Tostanoski; Lauren Peter; Noe B Mercado; Katherine McMahan; Shant H Mahrokhian; Joseph P Nkolola; Jinyan Liu; Zhenfeng Li; Abishek Chandrashekar; David R Martinez; Carolin Loos; Caroline Atyeo; Stephanie Fischinger; John S Burke; Matthew D Slein; Yuezhou Chen; Adam Zuiani; Felipe J N Lelis; Meghan Travers; Shaghayegh Habibi; Laurent Pessaint; Alex Van Ry; Kelvin Blade; Renita Brown; Anthony Cook; Brad Finneyfrock; Alan Dodson; Elyse Teow; Jason Velasco; Roland Zahn; Frank Wegmann; Esther A Bondzie; Gabriel Dagotto; Makda S Gebre; Xuan He; Catherine Jacob-Dolan; Marinela Kirilova; Nicole Kordana; Zijin Lin; Lori F Maxfield; Felix Nampanya; Ramya Nityanandam; John D Ventura; Huahua Wan; Yongfei Cai; Bing Chen; Aaron G Schmidt; Duane R Wesemann; Ralph S Baric; Galit Alter; Hanne Andersen; Mark G Lewis; Dan H Barouch
Journal:  Science       Date:  2020-05-20       Impact factor: 47.728

7.  The antigenic anatomy of SARS-CoV-2 receptor binding domain.

Authors:  Wanwisa Dejnirattisai; Daming Zhou; Helen M Ginn; Helen M E Duyvesteyn; Piyada Supasa; James Brett Case; Yuguang Zhao; Thomas S Walter; Alexander J Mentzer; Chang Liu; Beibei Wang; Guido C Paesen; Jose Slon-Campos; César López-Camacho; Natasha M Kafai; Adam L Bailey; Rita E Chen; Baoling Ying; Craig Thompson; Jai Bolton; Alex Fyfe; Sunetra Gupta; Tiong Kit Tan; Javier Gilbert-Jaramillo; William James; Michael Knight; Miles W Carroll; Donal Skelly; Christina Dold; Yanchun Peng; Robert Levin; Tao Dong; Andrew J Pollard; Julian C Knight; Paul Klenerman; Nigel Temperton; David R Hall; Mark A Williams; Neil G Paterson; Felicity K R Bertram; C Alistair Siebert; Daniel K Clare; Andrew Howe; Julika Radecke; Yun Song; Alain R Townsend; Kuan-Ying A Huang; Elizabeth E Fry; Juthathip Mongkolsapaya; Michael S Diamond; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

8.  Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.

Authors:  Thomas F Rogers; Fangzhu Zhao; Deli Huang; Nathan Beutler; Alison Burns; Wan-Ting He; Oliver Limbo; Chloe Smith; Ge Song; Jordan Woehl; Linlin Yang; Robert K Abbott; Sean Callaghan; Elijah Garcia; Jonathan Hurtado; Mara Parren; Linghang Peng; Sydney Ramirez; James Ricketts; Michael J Ricciardi; Stephen A Rawlings; Nicholas C Wu; Meng Yuan; Davey M Smith; David Nemazee; John R Teijaro; James E Voss; Ian A Wilson; Raiees Andrabi; Bryan Briney; Elise Landais; Devin Sok; Joseph G Jardine; Dennis R Burton
Journal:  Science       Date:  2020-06-15       Impact factor: 47.728

9.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

Authors:  Alexandra C Walls; Young-Jun Park; M Alejandra Tortorici; Abigail Wall; Andrew T McGuire; David Veesler
Journal:  Cell       Date:  2020-03-09       Impact factor: 41.582

10.  The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

Authors:  Lakshmanane Premkumar; Bruno Segovia-Chumbez; Ramesh Jadi; David R Martinez; Rajendra Raut; Alena Markmann; Caleb Cornaby; Luther Bartelt; Susan Weiss; Yara Park; Caitlin E Edwards; Eric Weimer; Erin M Scherer; Nadine Rouphael; Srilatha Edupuganti; Daniela Weiskopf; Longping V Tse; Yixuan J Hou; David Margolis; Alessandro Sette; Matthew H Collins; John Schmitz; Ralph S Baric; Aravinda M de Silva
Journal:  Sci Immunol       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.